Wed, Apr 15 · 8:30

The stage is set: Medical leadership must now drive the era of value-based care 

Our reorientation around patient value is fundamentally changing the nature of the medical function. Customers are crying out for science-driven, authentic interaction. Capable leaders must balance face-to-face relationships with managing RWE and making smarter connections across the lifecycle. Patients want to be better informed and better educated: we need to get them there.

The ability for our industry to make this leap depends entirely on whether medical acts decisively and pro-actively. Make no mistake, medical affairs can repair the reputation of pharma while meeting the value needs of an increasingly complex web of stakeholders.

It sounds like a mountain to climb, but together we can get there. We’re pulling together panels of medical leaders to break down the various permutations of what’s possible. Digital transformation and appropriate use of AI is critical, with new tools available to streamline and coordinate customer interaction.

The message is clear: medical, it’s time to step up. Join us at eyeforpharma Philadelphia to discover how.

Key Medical Affairs themes:

Your new role in 2020 and beyond:

Hear industry leaders deconstruct the future model of medical. Understand how your role and goals will change in the era of value-based care.

Become the custodian of value:

Set the Evidence and Value strategy across the lifecycle, by becoming the cross-functional authority on value and steering RWE positioning.

Create a field force capable of change:

As medical steps up the vision, capacity need to keep pace. Discover your blueprint how creating and managing an effective field engagement capability.

Brochure    https://go.evvnt.com/547622-3?pid=5731 

Prices:

Pharma Silver Pass: USD 1699.0,

Solution Provider Silver Pass: USD 2199.0

Speakers: Rob Scott CMO Abbvie, Eddie Power VP, North America Medical Affairs, Hospital Business Pfizer, Paul Rowe, MD VP, Head of Global Medical, Immunology Sanofi Genzyme, Rachele Berria, MD PhD VP, Head of Medical Affairs, US BioPharmaceuticals AstraZeneca, Sebastian Sorsaburu VP Medical Affairs Amgen, Sonal Bhatia, MD VP, North America Medical Lead, Rare Disease Pfizer, Teresa Griesing VP, North America Medical Affairs Pfizer, Michael Norton VP, Head US Medical Affairs Abbvie, Meg Heim VP, Global Head of Scientific Engagement Strategy, Operations and Program Management Sanofi, Christopher Keenan Head, Worldwide Medical Customer Engagement, Medical Capabilities Bristol-Myers Squibb, Nicky Kelepouris US Medical Director-Growth Hormone Novo Nordisk, Mary Andrews CEO The Magic Foundation